Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
China Biotechs See Manufacturing Disruption As Cases Hit Suzhou
Shanghai Lockdown GDP Impact
Apr 14 2022
•
By
Brian Yang
CHINA BIOTECH CLUSTER SUZHOU REPORTS INCREASING COVID CASES, IMPOSES RESTRICTIONS • Source: Shutterstock
More from China
More from Focus On Asia